Fig. 1 · Structure
Documents & Downloads
LMP2A (426-434)
IFN-γ Inducer
LMP2A (426-434) is an HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope derived from the Epstein-Barr virus (EBV) latent membrane protein 2A. This peptide is capable of inducing a robust interferon-gamma (IFN-γ) secretion response in individuals with various HLA-A*02 subtypes, leading to the activation and expansion of CD8+ IFN-γ+ T cells. LMP2A (426-434) specifically engages CTLs to target and eliminate cells expressing LMP2A, making it a valuable tool for investigating EBV-associated malignancies, including Hodgkin's disease and nasopharyngeal carcinoma.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inducer |
| CAS Number | 152274-91-4 |
| Applications | IFN-γ Inducer |
| Formula | C39H71N9O11S2 |
| Molecular Weight | 906.16 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.